Faculty profile

Julia Cadrin-Tourigny

ResearcherUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.

Julia Cadrin-Tourigny

Researcher

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
68 publications in the last five years, latest in 2026.
Senior (last) author on 5 recent papers, a sign of leading a research group.
Principal investigator on 3 research grants (3 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

1,234

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cardiac Magnetic Resonance Cardiomyopathy Electrocardiography Genetics Heart Failure Implantable Defibrillators Sudden Cardiac Death Ventricular Tachycardia

Latest papers

Evaluation of atrial fibrillation polygenic risk scores for the prediction of arrhythmia recurrence after atrial fibrillation ablation.
Heart rhythm · 2026
Tetralogy of Fallot: electrophysiology-guided surgical ablation during pulmonary valve replacement.
European heart journal · 2026
Foundation models for electrocardiogram interpretation: clinical implications.
European heart journal · 2026

All 94 publications

Latest funding

Precision Diagnosis and Management of Cardiogenetics: The Hearts in Rhythm Organization (HiRO)
CIHR · 2026 · Co-investigator
$1,095,100
Multimodality event prediction in non-ischemic cardiomyopathy
CIHR · 2024 · Nominated PI
$1,526,175
Targeted Therapy with Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Right Ventricular Cardiomyopathy (TARGETED-ARVC)
CIHR · 2022 · Principal investigator
$2,729,174

All 5 grants and awards

94 publications.

Evaluation of atrial fibrillation polygenic risk scores for the prediction of arrhythmia recurrence after atrial fibrillation ablation.

Petzl AM, Jordà P, Jeuken A, Henarejos-Castillo I, Aguilar M, Dyrda K, Guerra PG, Khairy P, Mondésert B, Raymond-Paquin A, Roy D, Thibault B, Macle L, Cadrin-Tourigny J, Rivard L, Tardif JC, Tadros R

Heart rhythm2026

DOI: 10.1016/j.hrthm.2026.08.022 PMID: 42632507

Tetralogy of Fallot: electrophysiology-guided surgical ablation during pulmonary valve replacement.

Dib N, Poirier N, Kamp A, Seslar SP, Robinson MR, Alonso PA, Honfo SH, Bessière F, Waldmann V, Dore A, Mongeon FP, Bouhout I, Chaix MA, Ibrahim R, Dyrda K, Raymond-Paquin A, Cadrin-Tourigny J, Petzl AM, Tadros R, Aguilar M, Guerra PG, Rivard L, Macle L, Thibault B, Roy D, Mondésert B, Khairy P

European heart journal2026

DOI: 10.1093/eurheartj/ehag329 PMID: 42206474

Foundation models for electrocardiogram interpretation: clinical implications.

Nolin-Lapalme A, Sowa A, Delfrate J, Tastet O, Corbin D, Kulbay M, Ozdemir D, Noël MJ, Marois-Blanchet FC, Harvey F, Sharma S, Ansari M, Chiu IM, D'souza V, Friedman SF, Chassé M, Potter BJ, Afilalo J, Elias PA, Jabbour G, Bahani M, Dubé MP, Boyle PM, Chatterjee NA, Barrios J, Tison GH, Ouyang D, Maddah M, Khurshid S, Cadrin-Tourigny J, Tadros R, Hussin J, Avram R

European heart journal2026

DOI: 10.1093/eurheartj/ehaf1119 PMID: 41568699

External validation of the DSP-risk score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy-associated genetic variants.

Gasperetti A, Bauce B, Protonotarios A, Murray B, Tichnell C, Martini M, Syrris P, Smith E, Ferro MD, Paldino A, Sinagra G, Iascone M, Iorio AM, Scotto R, Iseppi M, Calò L, Crescenzi C, Schiavone M, Ravaro S, Crotti L, Vargas DI, Olsen PAS, Graziosi M, Biagini E, Peretto G, Peters S, Apostu A, Jurçut R, Yap SC, Saguner AM, Duru F, Zimmerman S, Chen L, Felice T, Raineri C, Dusi V, Carrillo-Mora L, Cabrera-Romero E, Gimeno JR, Fernández-Sellers C, Zorio E, Ciabatti M, Fico V, Targetti M, Pieroni M, Cadrin-Tourigny J, Parikh VN, Muller S, Te Riele ASJM, van Tintelen P, Cox M, Helms A, Haugaa K, Pilochou K, Taylor M, Mestroni L, Elliott P, Merlo M, Arbelo E, Wu KC, James CA, Calkins H, Carrick RT

Heart rhythm2026

DOI: 10.1016/j.hrthm.2026.04.038 PMID: 42055101

Crossed wires: a shocking case of an subcutaneous-ICD lead jailed by sternal wires.

Gencher JA, Raymond-Paquin A, Cadrin-Tourigny J

European heart journal. Case reports2026Senior author

DOI: 10.1093/ehjcr/ytag193 PMID: 41883601

Ischemic Heart Disease With Right Ventricular Involvement Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy.

De Carolis M, Terrone D, Nosair M, Cadrin-Tourigny J, Tadros R

JACC. Case reports2026

DOI: 10.1016/j.jaccas.2025.106784 PMID: 41532905

The Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Selection, Implantation, and Management of Patients With Cardiac Implantable Electronic Devices

Andrade JG, Joza J, Chew DS, Ayala-Paredes F, Bennett MT, Essebag V, Greiss I, Hawkins NM, Khoo C, Kulyk K

Canadian Journal of Cardiology20268 citations

DOI: 10.1016/j.cjca.2025.08.363

Left Ventricular Late Gadolinium Enhancement for Arrhythmic Risk Prediction in ARVC

De Marco C, Asatryan B, Riele ASJMT, Di Marco A, Gasperetti A, Delinière A, Roberts JD, Jensen HK, Davies B, Krahn AD

Circulation: Arrhythmia and Electrophysiology20266 citationsSenior author

DOI: 10.1161/circep.125.014265

RBM20 Truncating Variants and Human Cardiomyopathy

Floyd BJ, Njoroge JN, Krysov VA, Gomes B, Murtha R, Aribeana C, Cannie D, Smith E, Paldino A, Brown EE

JAMA cardiology20264 citations

DOI: 10.1001/jamacardio.2026.0401

Polygenic and Monogenic Contributions to Tachycardia-Associated Cardiomyopathy

Safabakhsh S, Jordà P, Grondin S, Henarejos-Castillo I, Fazeli A, Laksman Z, Parker J, Yamani NE, Benhenda N, Aguilar M

Circulation20262 citations

DOI: 10.1161/circulationaha.125.076235

Precision Diagnosis and Management of Cardiogenetics: The Hearts in Rhythm Organization (HiRO)

Co-investigatorCIHR2026Project Grant

Principal investigators: Krahn, Andrew D

Keywords: Artificial Intelligence; Diagnosis; Genetics; Inherited Cardiac Conditions; Polygenic Risk Score; Precision Medicine; Registry; Risk Management

$1,095,100

Multimodality event prediction in non-ischemic cardiomyopathy

Nominated PICIHR2024Project Grant

Principal investigators: Cadrin-Tourigny, Julia; Roston, Thomas M; Tadros, Rafik; Tremblay-Gravel, Maxime

Keywords: Cardiac Magnetic Resonance; Cardiomyopathy; Electrocardiography; Genetics; Heart Failure; Implantable Defibrillators; Sudden Cardiac Death; Ventricular Tachycardia

$1,526,175

Targeted Therapy with Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Right Ventricular Cardiomyopathy (TARGETED-ARVC)

Principal investigatorCIHR2022Operating Grant: Clinical Trials Projects

Principal investigators: Roberts, Jason D; Cadrin-Tourigny, Julia; Connolly, Stuart J; Gollob, Michael H; Healey, Jeff S; Krahn, Andrew D

Keywords: Cardiomyopathy; Clinical Trials; Drug Development; Genetics; Sudden Cardiac Death

$2,729,174

Targeted Therapy with Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Right Ventricular Cardiomyopathy (TARGETED-ARVC)

Principal investigatorCIHR2022Operating Grant: Clinical Trials Projects - Indirect Costs

Principal investigators: Roberts, Jason D; Cadrin-Tourigny, Julia; Connolly, Stuart J; Gollob, Michael H; Healey, Jeff S; Krahn, Andrew D

Keywords: Cardiomyopathy; Clinical Trials; Drug Development; Genetics; Sudden Cardiac Death

$682,294

Complex genetics of hypertrophic cardiomyopathy: Towards an integration of polygenic risk in clinical care

Co-investigatorCIHR2019Project Grant

Principal investigators: Tadros, Rafik; Lettre, Guillaume

Keywords: Cardiac Arrhythmia; Cardiac Magnetic Resonance; Cardiac Ultrasound; Genetics; Genome-Wide Association Study; Hypertrophic Cardiomyopathy; Polygenic Risk Score

$1,038,180

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Julia Cadrin-Tourigny

Research

Latest papers

Latest funding

Evaluation of atrial fibrillation polygenic risk scores for the prediction of arrhythmia recurrence after atrial fibrillation ablation.

Tetralogy of Fallot: electrophysiology-guided surgical ablation during pulmonary valve replacement.

Foundation models for electrocardiogram interpretation: clinical implications.

External validation of the DSP-risk score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy-associated genetic variants.

Crossed wires: a shocking case of an subcutaneous-ICD lead jailed by sternal wires.

Ischemic Heart Disease With Right Ventricular Involvement Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy.

The Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Selection, Implantation, and Management of Patients With Cardiac Implantable Electronic Devices

Left Ventricular Late Gadolinium Enhancement for Arrhythmic Risk Prediction in ARVC

RBM20 Truncating Variants and Human Cardiomyopathy

Polygenic and Monogenic Contributions to Tachycardia-Associated Cardiomyopathy

Precision Diagnosis and Management of Cardiogenetics: The Hearts in Rhythm Organization (HiRO)

Multimodality event prediction in non-ischemic cardiomyopathy

Targeted Therapy with Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Right Ventricular Cardiomyopathy (TARGETED-ARVC)

Targeted Therapy with Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Right Ventricular Cardiomyopathy (TARGETED-ARVC)

Complex genetics of hypertrophic cardiomyopathy: Towards an integration of polygenic risk in clinical care

Frequent collaborators

Rafik Tadros

Paul Khairy

Jason Roberts

Laurent Macle

Léna Rivard

Jeff Healey

Denis Roy

Denis Roy

Shubhayan Sanatani

Christian Steinberg

Jacqueline Joza

Jean-Claude Tardif

Jean-Claude Tardif

Maxime Tremblay-Gravel

Anne Fournier

Laura Arbour

Robert Avram

Habib Khan

Atul Verma

Stanley Nattel

Guillaume Lettre

Zachary Laksman

Ratika Parkash

Robert Hamilton

Judith Brouillette

Julie Hussin

Martin Green

Sharmila Udupa

Nathaniel Hawkins